These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36907174)

  • 1. Chromosome 18 Loss of Heterozygosity in Small Intestinal Neuroendocrine Tumours: Multi-Omic and Tumour Composition Analyses.
    Waterfield S; Yousefi P; Webster A; Relton C; Thirlwell C; Suderman M
    Neuroendocrinology; 2023; 113(9):915-923. PubMed ID: 36907174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential methylation of G-protein coupled receptor signaling genes in gastrointestinal neuroendocrine tumors.
    Byun S; Affolter KE; Snow AK; Curtin K; Cannon AR; Cannon-Albright LA; Thota R; Neklason DW
    Sci Rep; 2021 Jun; 11(1):12303. PubMed ID: 34112938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor.
    Karpathakis A; Dibra H; Pipinikas C; Feber A; Morris T; Francis J; Oukrif D; Mandair D; Pericleous M; Mohmaduvesh M; Serra S; Ogunbiyi O; Novelli M; Luong T; Asa SL; Kulke M; Toumpanakis C; Meyer T; Caplin M; Meyerson M; Beck S; Thirlwell C
    Clin Cancer Res; 2016 Jan; 22(1):250-8. PubMed ID: 26169971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMAD4 haploinsufficiency in small intestinal neuroendocrine tumors.
    Hofving T; Elias E; Rehammar A; Inge L; Altiparmak G; Persson M; Kristiansson E; Johansson ME; Nilsson O; Arvidsson Y
    BMC Cancer; 2021 Jan; 21(1):101. PubMed ID: 33509126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics and epigenetics in small intestinal neuroendocrine tumours.
    Stålberg P; Westin G; Thirlwell C
    J Intern Med; 2016 Dec; 280(6):584-594. PubMed ID: 27306880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The landscape of molecular alterations in pancreatic and small intestinal neuroendocrine tumours.
    Scarpa A
    Ann Endocrinol (Paris); 2019 Jun; 80(3):153-158. PubMed ID: 31072588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent silencing of RASSF1A by DNA methylation in thymic neuroendocrine tumours.
    Kajiura K; Takizawa H; Morimoto Y; Masuda K; Tsuboi M; Kishibuchi R; Wusiman N; Sawada T; Kawakita N; Toba H; Yoshida M; Kawakami Y; Naruto T; Imoto I; Tangoku A; Kondo K
    Lung Cancer; 2017 Sep; 111():116-123. PubMed ID: 28838380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Immune Landscape in Pancreatic and Ileal Neuroendocrine Tumours Demonstrates an Immune Cold Tumour Microenvironment.
    Tanno L; Naheed S; Dunbar J; Tod J; Lopez MA; Taylor J; Machado M; Green B; Ashton-Key M; Chee SJ; Wood O; Pearce NW; Thomas GJ; Friedmann PS; Cave J; Ottensmeier CH
    Neuroendocrinology; 2022; 112(4):370-383. PubMed ID: 34157710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of chromosome 18 loss of heterozygosity in multifocal ileal neuroendocrine tumors.
    Zhang Z; Mäkinen N; Kasai Y; Kim GE; Diosdado B; Nakakura E; Meyerson M
    Genes Chromosomes Cancer; 2020 Sep; 59(9):535-539. PubMed ID: 32291827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct DNA Methylation Signatures in Neuroendocrine Tumors Specific for Primary Site and Inherited Predisposition.
    Tirosh A; Killian JK; Petersen D; Zhu YJ; Walker RL; Blau JE; Nilubol N; Patel D; Agarwal SK; Weinstein LS; Meltzer P; Kebebew E
    J Clin Endocrinol Metab; 2020 Oct; 105(10):3285-94. PubMed ID: 32706863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors.
    Walter D; Harter PN; Battke F; Winkelmann R; Schneider M; Holzer K; Koch C; Bojunga J; Zeuzem S; Hansmann ML; Peveling-Oberhag J; Waidmann O
    Sci Rep; 2018 Feb; 8(1):3811. PubMed ID: 29491456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and epigenetic prognosticators of neuroendocrine tumours of the GI tract, liver, biliary tract and pancreas: A systematic review and meta-analysis.
    Mestre-Alagarda C; Srirajaskanthan R; Zen Y; Giwa M; Howard M; Ooft ML
    Histopathology; 2024 Jan; 84(2):255-265. PubMed ID: 37565289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors: an in vivo and in vitro study.
    Fotouhi O; Adel Fahmideh M; Kjellman M; Sulaiman L; Höög A; Zedenius J; Hashemi J; Larsson C
    Epigenetics; 2014 Jul; 9(7):987-97. PubMed ID: 24762809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exome Sequencing and CNV Analysis on Chromosome 18 in Small Intestinal Neuroendocrine Tumors: Ruling Out a Suspect?
    Delgado Verdugo A; Crona J; Maharjan R; Hellman P; Westin G; Björklund P
    Horm Metab Res; 2015 Jun; 47(6):452-5. PubMed ID: 25354328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase activation in small intestinal neuroendocrine tumours is associated with aberrant
    Fotouhi O; Ghaderi M; Wang N; Zedenius J; Kjellman M; Xu D; Juhlin CC; Larsson C
    Epigenetics; 2019 Dec; 14(12):1224-1233. PubMed ID: 31322481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization.
    Hashemi J; Fotouhi O; Sulaiman L; Kjellman M; Höög A; Zedenius J; Larsson C
    BMC Cancer; 2013 Oct; 13():505. PubMed ID: 24165089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of primary tumour resection without curative intent in patients with metastatic neuroendocrine tumours of the small intestine and right colon: meta-analysis.
    Van Den Heede K; Chidambaram S; Van Slycke S; Brusselaers N; Warfvinge CF; Ohlsson H; Nordenström E; Almquist M
    Br J Surg; 2022 Feb; 109(2):191-199. PubMed ID: 34941998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours.
    Rico K; Duan S; Pandey RL; Chen Y; Chakrabarti JT; Starr J; Zavros Y; Else T; Katona BW; Metz DC; Merchant JL
    BMJ Open Gastroenterol; 2021 Nov; 8(1):. PubMed ID: 34750164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
    Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
    Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine.
    Simbolo M; Vicentini C; Mafficini A; Fassan M; Pedron S; Corbo V; Mastracci L; Rusev B; Pedrazzani C; Landoni L; Grillo F; Cingarlini S; Rindi G; Luchini C; Scarpa A; Lawlor RT
    Virchows Arch; 2018 Dec; 473(6):709-717. PubMed ID: 30219970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.